THESEUS PHARMACEUTICALS, INC. Comprehensive Income
THESEUS PHARMACEUTICALS, INC. reported Comprehensive Income of -$13.29 million for the 3-month period ending 2023-09-30, per its 10-Q filed 2023-11-17.
Discontinued › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2023-11-17
- THESEUS PHARMACEUTICALS, INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2023-09-30 was -$13.29M.
- THESEUS PHARMACEUTICALS, INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2023-06-30 was -$15.21M.
- THESEUS PHARMACEUTICALS, INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2023-03-31 was -$14.36M.
- THESEUS PHARMACEUTICALS, INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2022-12-31 was -$13.55M.
- THESEUS PHARMACEUTICALS, INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2022 was -$50.99M.
- THESEUS PHARMACEUTICALS, INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2021 was -$27.31M.
- THESEUS PHARMACEUTICALS, INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2020 was -$12.00M.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month |
|---|---|---|---|---|
| 2023-09-30 | -$13.29M 10-Q · filed 2023-11-17 | -$28.50M derived: sum of 2 quarters · filed 2023-11-17 | -$42.85M 10-Q · filed 2023-11-17 | -$56.41M derived: sum of 4 quarters · filed 2023-11-17 |
| 2023-06-30 | -$15.21M 10-Q · filed 2023-08-10 | -$29.57M 10-Q · filed 2023-08-10 | -$43.12M derived: sum of 3 quarters · filed 2023-08-10 | -$58.08M derived: sum of 4 quarters · filed 2023-11-17 |
| 2023-03-31 | -$14.36M 10-Q · filed 2023-05-11 | -$27.91M derived: sum of 2 quarters · filed 2023-05-11 | -$42.88M derived: sum of 3 quarters · filed 2023-11-17 | -$54.73M derived: sum of 4 quarters · filed 2023-11-17 |
| 2022-12-31 | -$13.55M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | -$28.52M derived: sum of 2 quarters · filed 2023-11-17 | -$40.37M derived: sum of 3 quarters · filed 2023-11-17 | -$50.99M 10-K · filed 2023-03-09 |
| 2022-09-30 | -$14.96M 10-Q · filed 2023-11-17 | -$26.82M derived: sum of 2 quarters · filed 2023-11-17 | -$37.44M 10-Q · filed 2023-11-17 | -$46.10M derived: sum of 4 quarters · filed 2023-11-17 |
| 2022-06-30 | -$11.85M 10-Q · filed 2023-08-10 | -$22.48M 10-Q · filed 2023-08-10 | -$31.13M derived: sum of 3 quarters · filed 2023-08-10 | -$38.51M derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | -$10.63M 10-Q · filed 2023-05-11 | -$19.28M derived: sum of 2 quarters · filed 2023-05-11 | -$26.65M derived: sum of 3 quarters · filed 2023-05-11 | -$33.46M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | -$8.66M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | -$16.03M derived: sum of 2 quarters · filed 2023-03-09 | -$22.84M derived: sum of 3 quarters · filed 2023-03-09 | -$27.31M 10-K · filed 2023-03-09 |
| 2021-09-30 | -$7.37M 10-Q · filed 2022-11-03 | -$14.18M derived: sum of 2 quarters · filed 2022-11-03 | -$18.65M 10-Q · filed 2022-11-03 | -$21.54M derived: sum of 4 quarters · filed 2022-11-03 |
| 2021-06-30 | -$6.81M 10-Q · filed 2022-08-11 | -$11.28M 10-Q · filed 2022-08-11 | -$14.17M derived: sum of 3 quarters · filed 2022-08-11 | -$15.60M derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | -$4.47M 10-Q · filed 2022-05-12 | -$7.36M derived: sum of 2 quarters · filed 2022-05-12 | -$8.79M derived: sum of 3 quarters · filed 2022-05-12 | |
| 2020-12-31 | -$2.89M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | -$4.32M derived: sum of 2 quarters · filed 2022-03-10 | -$12.00M 10-K · filed 2022-03-10 | |
| 2020-09-30 | -$1.43M 10-Q · filed 2021-11-15 | -$9.11M 10-Q · filed 2021-11-15 |